{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:27:44Z","timestamp":1791329264151,"version":"4.3.1"},"reference-count":55,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>MLL5 is a divergent member of the Drosophila Trithorax-related (SET) domain and plant homeodomain (PHD) domain-containing chromatin regulators that are involved in the regulation of transcriptional \u201cmemory\u201d during differentiation. Human MLL5 is located on chromosome 7q22, which frequently is deleted in myeloid leukemias, suggesting a possible role in hemopoiesis. To address this question, we generated a loss-of-function allele (Mll5tm1Apa) in the murine Mll5 locus. Unlike other Mll genes, Mll5tm1Apa homozygous mice are viable but display defects in immunity and hematopoiesis. First, Mll5tm1Apa homozygous mice show increased susceptibility to spontaneous eye infections, associated with a cell-autonomous impairment of neutrophil function. Second, Mll5tm1Apa\/tm1Apa mice exhibit a mild impairment of erythropoiesis. Third, Mll5tm1Apa\/tm1Apa hematopoietic stem cells (HSCs) have impaired competitive repopulating capacity both under normal conditions and when subjected to self-renewal stimulation by NUP98-HOXA10. Fourth, Mll5tm1Apa homozygous HSCs show a dramatic sensitivity to DNA demethylation\u2013induced differentiation (5-azadeoxycytidine). Taken together, our data show that MLL5 is involved in terminal myeloid differentiation and the regulation of HSC self-renewal by a mechanism that involves DNA methylation. These data warrant investigation of MLL5 expression levels as a predictive marker of demethylating-agent response in patients with myelodysplastic syndromes and leukemias and identify MLL5 as a key regulator of normal hematopoiesis.<\/jats:p>","DOI":"10.1182\/blood-2008-06-162263","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T23:44:35Z","timestamp":1224027875000},"page":"1432-1443","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["Loss of Mll5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation"],"prefix":"10.1182","volume":"113","author":[{"given":"Michael","family":"Heuser","sequence":"first","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian B.","family":"Yap","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malina","family":"Leung","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Ruiz","family":"de Algara","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaeddin","family":"Tafech","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McKinney","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dixon","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals Cambridge Ltd., Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Thresher","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals Cambridge Ltd., Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Colledge","sequence":"additional","affiliation":[{"name":"Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Carlton","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals Cambridge Ltd., Cambridge, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Keith","family":"Humphries","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111805282771600_B1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nsmb1128","article-title":"Regulation of MLL1 H3K4 methyltransferase activity by its core components.","volume":"13","author":"Dou","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"2019111805282771600_B2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2005.03.036","article-title":"WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.","volume":"121","author":"Wysocka","year":"2005","journal-title":"Cell"},{"key":"2019111805282771600_B3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0968-0004(03)00007-0","article-title":"Structure of SET domain proteins: a new twist on histone methylation.","volume":"28","author":"Marmorstein","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"2019111805282771600_B4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature04835","article-title":"ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression.","volume":"442","author":"Shi","year":"2006","journal-title":"Nature"},{"key":"2019111805282771600_B5","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1074\/jbc.C600286200","article-title":"Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36.","volume":"282","author":"Shi","year":"2007","journal-title":"J Biol Chem"},{"key":"2019111805282771600_B6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nature06431","article-title":"RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination.","volume":"450","author":"Matthews","year":"2007","journal-title":"Nature"},{"key":"2019111805282771600_B7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"key":"2019111805282771600_B8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters.","volume":"10","author":"Milne","year":"2002","journal-title":"Mol Cell"},{"key":"2019111805282771600_B9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"2019111805282771600_B10","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.1073\/pnas.0607313103","article-title":"Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111805282771600_B11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1149042","article-title":"Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.","volume":"318","author":"Lee","year":"2007","journal-title":"Science"},{"key":"2019111805282771600_B12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbagrm.2007.11.006","article-title":"Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.","volume":"1779","author":"Ansari","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"2019111805282771600_B13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1242\/dev.02302","article-title":"Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development.","volume":"133","author":"Glaser","year":"2006","journal-title":"Development"},{"key":"2019111805282771600_B14","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1371\/journal.pone.0001499","article-title":"Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes.","volume":"3","author":"Sun","year":"2008","journal-title":"PLoS ONE"},{"key":"2019111805282771600_B15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.2036345100","article-title":"MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression.","volume":"101","author":"Deng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111805282771600_B16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12038-008-0019-6","article-title":"A gene-trap strategy identifies quiescence-induced genes in synchronized myoblasts.","volume":"33","author":"Sambasivan","year":"2008","journal-title":"J Biosci"},{"key":"2019111805282771600_B17","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1038\/sj.onc.1205615","article-title":"MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia.","volume":"21","author":"Emerling","year":"2002","journal-title":"Oncogene"},{"key":"2019111805282771600_B18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(92)90603-A","article-title":"The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.","volume":"71","author":"Gu","year":"1992","journal-title":"Cell"},{"key":"2019111805282771600_B19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.onc.1201211","article-title":"Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax.","volume":"15","author":"Prasad","year":"1997","journal-title":"Oncogene"},{"key":"2019111805282771600_B20","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1038\/sj.onc.1203291","article-title":"MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines.","volume":"18","author":"Huntsman","year":"1999","journal-title":"Oncogene"},{"key":"2019111805282771600_B21","first-page":"454","article-title":"Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects.","volume":"25","author":"Tan","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"2019111805282771600_B22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.stem.2007.05.019","article-title":"Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors.","volume":"1","author":"Jude","year":"2007","journal-title":"Cell Stem Cell"},{"key":"2019111805282771600_B23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.stem.2007.07.002","article-title":"Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal.","volume":"1","author":"McMahon","year":"2007","journal-title":"Cell Stem Cell"},{"key":"2019111805282771600_B24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/378505a0","article-title":"Altered Hox expression and segmental identity in Mll-mutant mice.","volume":"378","author":"Yu","year":"1995","journal-title":"Nature"},{"key":"2019111805282771600_B25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/geno.2001.6636","article-title":"Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.","volume":"77","author":"Kratz","year":"2001","journal-title":"Genomics"},{"key":"2019111805282771600_B26","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2006-04-014845","article-title":"High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.","volume":"108","author":"Heuser","year":"2006","journal-title":"Blood"},{"key":"2019111805282771600_B27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"key":"2019111805282771600_B28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.exphem.2007.02.012","article-title":"Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions.","volume":"35","author":"Ohta","year":"2007","journal-title":"Exp Hematol"},{"key":"2019111805282771600_B29","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood-2002-08-2484","article-title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.","volume":"101","author":"Pineault","year":"2003","journal-title":"Blood"},{"key":"2019111805282771600_B30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood-2003-10-3550","article-title":"NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation.","volume":"104","author":"Gurevich","year":"2004","journal-title":"Blood"},{"key":"2019111805282771600_B31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood-2007-03-080523","article-title":"MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients.","volume":"110","author":"Heuser","year":"2007","journal-title":"Blood"},{"key":"2019111805282771600_B32","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2008"},{"key":"2019111805282771600_B33","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"2019111805282771600_B34","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"2019111805282771600_B35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","article-title":"The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.","volume":"98","author":"Grimwade","year":"2001","journal-title":"Blood"},{"key":"2019111805282771600_B36","first-page":"1315","article-title":"Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.","volume":"7","author":"Morel","year":"1993","journal-title":"Leukemia"},{"key":"2019111805282771600_B37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2019111805282771600_B38","first-page":"1168","article-title":"Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.","volume":"90","author":"Sol\u00e9","year":"2005","journal-title":"Haematologica"},{"key":"2019111805282771600_B39","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1158\/0008-5472.CAN-07-0196","article-title":"BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.","volume":"67","author":"Omidvar","year":"2007","journal-title":"Cancer Res"},{"key":"2019111805282771600_B40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"2019111805282771600_B41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI21716","article-title":"EVI1 induces myelodysplastic syndrome in mice.","volume":"114","author":"Buonamici","year":"2004","journal-title":"J Clin Invest"},{"key":"2019111805282771600_B42","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2003-09-3262","article-title":"Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+\/\u2212SHIP\u2212\/\u2212 mice: a novel model of myelodysplasia.","volume":"103","author":"Moody","year":"2004","journal-title":"Blood"},{"key":"2019111805282771600_B43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature03915","article-title":"Role of nucleophosmin in embryonic development and tumorigenesis.","volume":"437","author":"Grisendi","year":"2005","journal-title":"Nature"},{"key":"2019111805282771600_B44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"key":"2019111805282771600_B45","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model.","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"key":"2019111805282771600_B46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-10-049783","article-title":"Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.","volume":"110","author":"Bullinger","year":"2007","journal-title":"Blood"},{"key":"2019111805282771600_B47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-7-64","article-title":"Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.","volume":"7","author":"Chandran","year":"2007","journal-title":"BMC Cancer"},{"key":"2019111805282771600_B48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.2036345100","article-title":"MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression.","volume":"101","author":"Deng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111805282771600_B49","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.biocel.2008.04.012","article-title":"RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest.","volume":"40","author":"Cheng","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2019111805282771600_B50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01080","article-title":"Active genes are tri-methylated at K4 of histone H3.","volume":"419","author":"Santos-Rosa","year":"2002","journal-title":"Nature"},{"key":"2019111805282771600_B51","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1073\/pnas.0800090105","article-title":"MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression.","volume":"105","author":"Erfurth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111805282771600_B52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.2001.02933.x","article-title":"Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2\u2032-deoxycytidine.","volume":"114","author":"L\u00fcbbert","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111805282771600_B53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2006-05-021162","article-title":"Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"2019111805282771600_B54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cncr.22376","article-title":"Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Cancer"},{"key":"2019111805282771600_B55","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood-2007-03-080630","article-title":"Preferential cytogenetic response to continuous intravenous low-dose decitabine (DAC) administration in myelodysplastic syndrome with monosomy 7.","volume":"110","author":"R\u00fcter","year":"2007","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/7\/1432\/1314134\/zh800709001432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/7\/1432\/1314134\/zh800709001432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T05:29:53Z","timestamp":1574054993000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/7\/1432\/26018\/Loss-of-Mll5-results-in-pleiotropic-hematopoietic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,2,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-06-162263","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}